Naslov
2411. One Dose Vancomycin Prophylaxis for In- Hospital Clostridioides difficile - Associated Disease
(2411. One Dose Vancomycin Prophylaxis for In- Hospital Clostridioides difficile - Associated Disease)

Autori
Papić, Neven ; Stemberger Marić, Lorna ; Dušek, Davorka ; Vince, Adriana

Izvornik
Open Forum Infectious Diseases (2328-8957) 6 (2019), Suppl.2; S832-S833

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Clostridioides difficile ; Healthcare-associated diarrhea ; Nosocomial infections ; vancomycin ; prophylaxis

Sažetak
Background Clostridioides difficile - associated disease (CDAD) is the most common cause of healthcare-associated diarrhea with increasing prevalence and mortality rates. Recent reports suggest that prophylactic administration of vancomycin or fidaxomicin might reduce in-hospital CDAD incidence. The aims of this study were to examine whether primary oral vancomycin prophylaxis (OVP) reduces the in- hospital incidence of CDAD in elderly patients treated with systemic antibiotics and its impact on 90-day readmission rate. Methods This single-center, retrospective cohort study included 484 patients ≥ 65 years who received antimicrobial therapy for ≥ 24 hours and were hospitalized for ≥ 72 hours during a 24-month period. Patients diagnosed with CDAD within the first 48 hours of hospitalization were excluded. OVP group received ≥ 1 dose of vancomycin 125 mg once per day. Results Patients within OVP group (122 ; 25.2%) had higher age adjusted Charlson comorbidity index (CCI) (8 ; IQR 6–10 vs. 6 ; 5–8), were more often hospitalized within 3 months (62 ; 50.8% vs. 121 ; 33.4%), more commonly received piperacillin/tazobactam (60 ; 49.2% vs. 81 ; 22.4%) and carbapenems (27 ; 22.1% vs. 43 ; 11.9%) with longer duration of antibiotic therapy (14 ; 10–20 vs 10 ; 10–14 days). CDAD was diagnosed in 3 (2.5%) patients in OVP, compared with 45 patients (12.4%, p = 0.0011) in control group. In logistic regression analysis CCI > 6 (OR 3.54 ; 95% CI 1.79–6.87), OVP (0.19 ; 0.06–0.57), nursing home residency (4.10 ; 2.40–7.02), carbapenems (3.14 ; 1.60–6.15) and piperacillin/tazobactam (5.43 ; 2.87– 10.14) were associated with CDAD. In this cohort, 28 (23.7%) patients from OVP and 69 (21.7%) patients from control group had 90-day readmission. 6 patients in OVP (4 new episodes) and 21 (14 new episodes) in control group were admitted for CDAD. Only CDAD during index hospitalization was associated with 90-day readmission (HR 4.60 ; 95% CI 1.93–10.96). Conclusion Primary OVP was highly effective in reducing the risk of in-hospital CDAD in elderly patients treated with systemic antimicrobial therapy. Prospective studies with follow-up are needed to define long-term efficacy and potential risks of this strategy.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA